van den Boom Esther 4
4 · Tyra Biosciences, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
van den Boom Esther
Chief Financial Officer
Transactions
- Award
Common Stock
2022-09-15$7.66/sh+1,452$11,120→ 121,897 total
Holdings
- 118,645(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.